NCT02878122 Study of Predictive Factors of Chemoresistance in Ovarian Cancer Status COMPLETED Phase N/A
NCT02873962 A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02869217 Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02867956 Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer Status COMPLETED Phase PHASE2
NCT02865811 Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT02856841 The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer Status COMPLETED Phase N/A
NCT02855944 ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Status COMPLETED Phase PHASE3
NCT02855697 Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer Status COMPLETED Phase EARLY_PHASE1
NCT02836028 A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer Status WITHDRAWN Phase PHASE2
NCT02830724 Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers Status RECRUITING Phase PHASE1/PHASE2
NCT02828618 Trial on Radical Upfront Surgery in Advanced Ovarian Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT02824328 A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers Status COMPLETED Phase N/A
NCT02821793 Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer Status COMPLETED Phase N/A
NCT02792959 Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging Status COMPLETED Phase NA
NCT02785887 Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients Status COMPLETED Phase NA
NCT02769546 Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis Status TERMINATED Phase N/A
NCT02766582 Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer Status COMPLETED Phase PHASE2
NCT02764333 TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer Status COMPLETED Phase PHASE2